Bragar Eagel & Squire, P.C. Warns ARDT Investors of March 9 Deadline

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has issued an urgent reminder to stockholders of Ardent Health, Inc. (NYSE: ARDT) about an important upcoming deadline related to their investor rights. The firm emphasizes that investors who purchased or acquired Ardent Health securities during a specific period and experienced financial losses should contact the firm before March 9, 2026, to discuss their legal options.

Summary of the Reminder

The notice highlights that a class action lawsuit has been filed against Ardent Health, Inc. in the United States District Court for the Middle District of Tennessee. The lawsuit represents all persons and entities who purchased or acquired Ardent Health securities between July 18, 2024 and November 12, 2025, inclusive (referred to as the “Class Period”).

Investors included in this group have until March 9, 2026 to move the court to be appointed as lead plaintiff in the class action. Serving as lead plaintiff allows an investor to represent the interests of the entire class and play a significant role in directing the litigation.

Allegations Against Ardent Health

According to the complaint, Ardent Health allegedly misreported its financial results during the class period. The suit claims the company reported higher amounts of accounts receivable and delayed recognizing losses on accounts they suspected were uncollectable. It also alleges that the company did not maintain sufficient professional malpractice liability insurance to cover potential claims arising from its operations.

The filing further states that on November 12, 2025, Ardent Health announced a downward revision of approximately $43 million in revenue for the third quarter of 2025. This adjustment was attributed to revised determinations of accounts receivable collectability following the company’s adoption of a new revenue accounting system and subsequent internal evaluations of historical collection trends.

When this news became public, Ardent Health’s stock price dropped sharply. On November 13, 2025 the stock closed at about $9.30 per share, down nearly 34% from its prior closing price of $14.05 per share the previous day. These losses are cited as the basis for the class action lawsuit.

Who Should Contact the Law Firm?

If you purchased or acquired Ardent Health securities during the class period and experienced losses, you may have legal rights and options. Bragar Eagel & Squire encourages those investors — whether long-term holders or those with information about the claim — to contact the firm. There is no cost or obligation for you to get in touch.

Investors can contact litigation partners Brandon Walker or Melissa Fortunato directly via phone, email, or a designated online contact form to request more information or begin participation in the action.

About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. is known for representing individual and institutional investors in a variety of securities and shareholder litigation, including class actions and derivative cases. The firm operates nationally, with offices across multiple U.S. states and routinely handles cases in both federal and state courts.

Attorney advertising: Prior results do not guarantee similar outcomes.

#ArdentHealth #ARDT #InvestorRights #ClassAction #SlimScan #GrowthStocks #CANSLIM